“Experimental Pharmacology & Oncology (EPO) GmbH uses 1st and 2nd generation NOG mice provided by Taconic for its preclinical oncology service. These mice are included in novel concepts for the development of personalized treatment options and especially suited for humanization strategies. We are very satisfied with the quality of mice, the reliability of shipment and the high level of scientific support. Further, we very much appreciate the competent and always friendly communication.”

Experimental Pharmacology & Oncology (EPO) GmbH

What our customers say:

“Working with Taconic has been a great pleasure for Pharmatest. We are impressed with the high quality services, top-level scientific support, and fast and clear communication. By using humanized mice provided by Taconic, we have been able to establish more predictive animal models to support immuno-oncology therapy development.”

Dr. Jenni Bernoulli, COO at Pharmatest

Immune System Engrafted Mice

Taconic Biosciences' NOG mice are immunodeficient mouse models which accept the engraftment of heterologous cells more readily than traditional immunodeficient models, making them exceptional candidates for the production of mice with human immune systems.

The ability to efficiently engraft and proliferate a functional human immune system in NOG mice supports in vivo research in a more translatable context, powering studies in a variety of applications.

Genetically Humanized Mice

Next-generation humanized mouse models emerge from the core NOG portfolio, with additional genetic modifications for increased translatability and effective modeling of the human immune system in a preclinical context.

Examples of these transgenic modifications include, but are not limited to: